We are live on
!
Find out more
ACM
Argyle Capital Management Portfolio holdings
AUM
$347M
1-Year Est. Return
44.33%
This Fund
S&P 500
This Quarter
Est. Return
+10.64%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$258M
AUM Growth
+$17.1M
(+7.1%)
Cap. Flow
-$6.18M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
29.2%
Holding
119
New
3
Increased
24
Reduced
64
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354K |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$329K |
| 3 |
Hewlett Packard
HPE
|
+$300K |
| 4 |
NVIDIA
NVDA
|
+$254K |
| 5 |
Southern Company
SO
|
+$249K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$3.16M |
| 2 |
Microsoft
MSFT
|
+$519K |
| 3 |
Pultegroup
PHM
|
+$378K |
| 4 |
Waste Management
WM
|
+$305K |
| 5 |
Caterpillar
CAT
|
+$272K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 18.13% |
| 3 | Industrials | 13.28% |
| 4 | Financials | 11.99% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pentair
PNR
$10.4B
| $384K | 0.15% |
4,500
| – | – |
|
102
Devon Energy
DVN
$52.1B
| $353K | 0.14% |
7,033
-568
| -7% | -$25.2K |
|
103
nVent Electric
NVT
$24.9B
| $352K | 0.14% |
4,666
| – | – |
|
104
Eastman Chemical
EMN
$8B
| $341K | 0.13% |
3,400
| – | – |
|
|
105
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $330K | 0.13% |
+3,595
| New | +$329K |
|
106
Crane Co
CR
$12.3B
| $324K | 0.13% |
2,400
| – | – |
|
|
107
NVIDIA
NVDA
$4.86T
| $316K | 0.12% |
+3,500
| New | +$254K |
|
108
Amazon
AMZN
$2.92T
| $271K | 0.1% |
1,500
| – | – |
|
109
Kennametal
KMT
$2.59B
| $264K | 0.1% |
10,567
| – | – |
|
110
Ingersoll Rand
IR
$32.6B
| $251K | 0.1% |
2,647
| – | – |
|
111
Teva Pharmaceuticals
TEVA
$40.8B
| $248K | 0.1% |
17,600
-1,450
| -8% | -$18.3K |
|
112
CenterPoint Energy
CNP
$27.7B
| $245K | 0.09% |
8,600
-600
| -7% | -$16.8K |
|
113
Novartis
NVS
$297B
| $230K | 0.09% |
2,375
| – | – |
|
114
Aflac
AFL
$64.9B
| $203K | 0.08% |
+2,370
| New | +$194K |
|
115
Viatris
VTRS
$20.4B
| $120K | 0.05% |
10,059
-354
| -3% | -$4.26K |
|
116
Newell Brands
NWL
$2.38B
| $108K | 0.04% |
13,500
-500
| -4% | -$3.98K |
|
117
Warner Bros
WBD
$65.9B
| $105K | 0.04% |
12,060
-942
| -7% | -$9.08K |
|
118
OraSure Technologies
OSUR
$279M
| $61.7K | 0.02% |
10,025
| – | – |
|
119
Labcorp
LH
$25B
| – | – |
-883
| Closed | -$201K |
|
Similar funds
GCP
AWA
WC
LAM
FFA
VW
1CP
NC
Argyle Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Argyle Capital Management held 119 positions worth $258M, up 7.1% from $241M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.4%. Argyle Capital Management opened 3 new positions and exited 1, leaving the 119-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
- Argyle Capital Management's largest Q1 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 3,595 shares worth $330K.
- Argyle Capital Management added most to Comcast in Q1 2024, an estimated $354K increase.
- Argyle Capital Management's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $3.16M.
- Argyle Capital Management fully exited Labcorp in Q1 2024, selling an estimated $201K.
- Argyle Capital Management's ten largest holdings make up 29% of its $258M portfolio in Q1 2024.
- Argyle Capital Management opened 3 new positions and closed 1 in Q1 2024.
- Argyle Capital Management's portfolio value rose 7.1% quarter-over-quarter to $258M.
Based on Argyle Capital Management's 13F filing for Q1 2024, filed 29 Apr 2024.